ETF Financial News

The short-term trend in pharma stocks appears positive, and pharma ETF could be a good option for a short-term long position, says Rupak De, Senior Technical Analyst at LKP Securities. In this chat with ET Markets, he also shares 3 stock ideas for the week — Kotak Mahindra Bank, JSW Steel and Godfrey Phillips. Edited excerpts:

The Trump administration may create powerful tailwinds for two vastly different market groups: Big banks and small cap stocks.

All the big swings on Wall Street show again how little investors control

In this article

Bank of America's top strategist Michael Hartnett claimed that the days of US stocks beating global markets consistently might come to an end, as per a report.

Zerodha Mutual Fund has announced the revision in the minimum amount criteria of Zerodha Gold ETF FoF.

Digital asset manager Grayscale unveiled a Dogecoin Trust Friday, expanding its crypto offerings.

In this article

In this article

President Donald Trump's return to the Oval Office ushered in a week of changes in the cryptocurrency industry.

Subscribe to enjoy similar stories. Irrationally exuberant investors who lose their shirts get a lot of attention. But there is another way to manage your money poorly: taking so little risk that you end up with little reward.

Wealthfront

In an exclusive ETMarkets Livestream interview, Subho Moulik, Founder & CEO, Appreciate — a leading expert in global market investments, shares valuable insights into why Indian investors are increasingly turning to the US markets. With a focus on diversification, high-return potential, and exposure to cutting-edge sectors like AI, biotech, and semiconductors, Moulik outlines the growing appeal of the US as a key investment destination. He also discusses the impact of political shifts, currency fluctuations, and emerging trends, offering a comprehensive view of how Indian investors can benefit from diversifying their portfolios internationally. Edited Excerpts – What factors are driving the trend of Indian investors increasingly looking to invest overseas, particularly in markets like the US? Subho Moulik: Let’s start with the fundamentals as to why the US is attractive and increasingly appealing to Indian investors.

In this article

The enduring popularity of European ETFs pushed net new assets for the year to a record $265.4bn – an increase of more than $80bn on the previous milestone – according to Invesco's latest European Demand Monitor.  Equity ETFs continued to be the star attraction in the final quarter of 2024, claiming 91% of net new assets in Q4 and 80% for the full year. Global ETF flows set to surpass $1trn this year With total net new assets of $211bn in 2024, equities beat their previous annual record set in 2021 by 50%. Despite the highest number of product launches of  fixed income ETFs sinc...

Greenlight Capital's David Einhorn thinks speculative behavior in the current bull market has ascended to a level beyond common sense.

ethical concerns.

«I think investors are beginning to understand that there are cheaper alternatives which give them similar growth profile, similar earnings growth profile in the medium term but available at far lower valuations,» says Manishi Raychaudhuri, Veteran Investor In Asian Equities. They say that if you are a long-term bull, ETF is the best and the cheapest way to go. So, I am just keeping it very, very, very simple. But your clients would say okay we know that already. Tell us what we do not know. So, what are you telling your clients, your prospective clients that what they do not know in terms of the market links, connections, and valuations? Manishi Raychaudhuri: Well, in the near term I am perhaps telling them not to invest in India, not even in the ETFs. In case you are looking for a parking space for your money, gold is a good alternative. Gold ETFs are what I am doing personally. So, yes, I will elaborate on all these things.

Subscribe to enjoy similar stories. The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a major discount to the broader market.

Imagine a day without Google, an Uber ride, WhatsApp, or even spreadsheets at work. Picture an evening without Instagram memes or relaxing on a weekend without Netflix. It seems almost unfathomable, doesn’t it? These platforms have woven themselves deeply into our daily lives, serving billions globally. So, why not seize the opportunity to invest in the companies that power these experiences?